Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 275 entries
View as:

Effect of Naltrexone in Achieving and Maintaining Abstinence From Alcohol in Patients With Cirrhosis.

Phase: N/A Priority: Normal
NCT ID: NCT04391764 Org: User:
Start: 12/06/20 End: 10/31/22 Due: 10/31/23

Effect of Novel Donor Lifestyle Optimisation Protocol on Liver Regeneration in Live Liver Donors

Phase: N/A Priority: Normal
NCT ID: NCT04565535 Org: User:
Start: 10/01/20 End: 04/30/22 Due: 04/30/23

Lactate Kinetics as a Predictor of Survival in ACLF With Septic Shock

Phase: N/A Priority: Normal
NCT ID: NCT06116305 Org: User:
Start: 11/05/23 End: 08/30/24 Due: 08/30/25

Effectiveness of Video Based Education Versus Music Therapy on Anxiety, Experience, and Co-operation Among Patients Undergoing Magnetic Resonance Imaging in Radiology Department at ILBS, New Delhi.

Phase: N/A Priority: Normal
NCT ID: NCT04545086 Org: User:
Start: 09/30/19 End: 11/05/19 Due: 11/05/20

Intragastric Balloon in Compensated NASH(Non Alcoholic Steato Hepatitis) Cirrhotics

Phase: N/A Priority: Normal
NCT ID: NCT03753438 Org: User:
Start: 08/02/16 End: 05/31/20 Due: 05/31/21

Tranexamic Acid for Acute Upper Gastrointestinal Bleed in Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT04489108 Org: User:
Start: 11/05/20 End: 04/30/22 Due: 04/30/23

To Evaluate the Safety and Efficacy of Sofosbuvir and Ribavirin in Patients With HCV (Genotype 3) Related Decompensated Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT02464631 Org: User:
Start: 06/30/15 End: 12/31/16 Due: 12/31/17

Effect of BCAA Supplementation on Muscle Mass, Muscle Quality and Molecular Markers of Muscle Regeneration in CLD Patients

Phase: N/A Priority: Normal
NCT ID: NCT04246918 Org: User:
Start: 06/01/20 End: 09/30/22 Due: 09/30/23

Effectiveness of Mindfulness Based Meditation on Well-being, Self Compassion & Cognizance Among Nurses Working in Intensive Care Units

Phase: N/A Priority: Normal
NCT ID: NCT04572464 Org: User:
Start: 06/14/19 End: 10/30/19 Due: 10/30/20

Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT03069339 Org: User:
Start: 03/15/17 End: 11/30/20 Due: 11/30/21

Efficacy and Safety of Pentoxifylline in Improving Oxygenation in Hepatopulmonary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05373134 Org: User:
Start: 05/05/22 End: 04/30/23 Due: 04/30/24

Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced Hypotension

Phase: N/A Priority: Normal
NCT ID: NCT06076330 Org: User:
Start: 09/30/23 End: 08/31/24 Due: 08/31/25

Restrictive Versus Liberal Red Blood Cell Transfusion in Patients of Cirrhosis With Septic Shock

Phase: N/A Priority: Normal
NCT ID: NCT03433508 Org: User:
Start: 12/15/18 End: 02/15/19 Due: 02/15/20

Sedation for Patients Undergoing Endoscopic Retrograde Cholangiopancreatography

Phase: N/A Priority: Normal
NCT ID: NCT04860167 Org: User:
Start: 09/10/18 End: 11/14/19 Due: 11/14/20

Three-Dimensional Vascular Reconstruction of the Pancreas on Multidetector Computed Tomography Images and Its Impact on Patients Undergoing Pancreaticoduodenectomy

Phase: N/A Priority: Normal
NCT ID: NCT05389917 Org: User:
Start: 05/30/22 End: 06/01/23 Due: 06/01/24

Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBV

Phase: N/A Priority: Normal
NCT ID: NCT04431375 Org: User:
Start: 06/22/20 End: 06/10/22 Due: 06/10/23

The Second COVID-19 Wave: Collateral Impact on Patients of Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT05167305 Org: User:
Start: 12/22/21 End: 12/31/21 Due: 12/31/22

Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma.

Phase: N/A Priority: Normal
NCT ID: NCT06244446 Org: User:
Start: 02/05/24 End: 01/31/25 Due: 01/31/26

Efficacy of Plasma Exchange Therapy vs Standard Medical Therapy in Severe Alcoholic Hepatitis With High Discriminant Function

Phase: N/A Priority: Normal
NCT ID: NCT06355726 Org: User:
Start: 04/09/24 End: 02/28/25 Due: 02/28/26

Role of Exercise in Chronic Liver Disease Patients Undergoing Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT06163001 Org: User:
Start: 12/15/23 End: 09/30/24 Due: 09/30/25

Efficacy and Safety of Sodium Benzoate in the Management of Hyperammonemia in Infants, Children and Adolescent With Chronic Liver Disease.

Phase: N/A Priority: Normal
NCT ID: NCT04022941 Org: User:
Start: 04/01/17 End: 12/31/18 Due: 12/31/19

Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites.

Phase: N/A Priority: Normal
NCT ID: NCT04013074 Org: User:
Start: 07/09/19 End: 07/31/20 Due: 07/31/21

Genetic Variants Associated With the Risk of Gall Stones and Cirrhosis.

Phase: N/A Priority: Normal
NCT ID: NCT06679738 Org: User:
Start: 11/10/24 End: 12/31/25 Due: 12/31/26

Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT02658786 Org: User:
Start: 01/31/16 End: 12/31/20 Due: 12/31/21

Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.

Phase: N/A Priority: Normal
NCT ID: NCT05767229 Org: User:
Start: 03/13/23 End: 11/02/24 Due: 11/02/25